# Real World Evidence Study of SYN023 in Children Exposed to Rabies

> **NCT07327307** · — · RECRUITING · sponsor: **Synermore Biologics (Suzhou) Co., Ltd.** · enrollment: 232 (estimated)

## Conditions studied

- Rabies Post-exposure Prophylaxis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07327307
- **Lead sponsor:** Synermore Biologics (Suzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-02
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 232 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07327307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07327307, "Real World Evidence Study of SYN023 in Children Exposed to Rabies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07327307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*